Form 4: Becton Dickinson Executive Sells Shares Under 10b5-1 Plan

Michael David Garrison, EVP & President, Medical at Becton Dickinson, sold 479 shares of common stock at a price of $197.28 per share on April 9, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• On April 9, 2025, Michael David Garrison, an Executive Vice President and President, Medical at Becton Dickinson & Co., sold 479 shares of common stock.
• The sale was executed at a price of $197.28 per share.
• Following the transaction, Garrison directly owns 4,887 shares of Becton Dickinson common stock.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 2, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-arranged trading plan and doesn't necessarily indicate a positive or negative outlook on the company's performance.

Industry Context

Executive stock sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on non-public information. The market typically views these sales in the context of the overall financial health and future prospects of the company.

Stakeholder Impact

• The sale of shares by an executive could be perceived neutrally or slightly negatively by shareholders, depending on the context and the size of the sale, but the existence of a 10b5-1 plan mitigates concerns about insider information.

Key Dates

Keywords

Form 4, Becton Dickinson, BDX, Insider Trading, Stock Sale, Executive, Garrison, 10b5-1 plan